(Q34659504)

3 August 2017

Urinary diazepam metabolite distribution in a chronic pain population (English)

1 reference

3 August 2017

0 references

0 references

Samantha Luk

1

1 reference

3 August 2017

Rabia S Atayee

series ordinal

2

1 reference

3 August 2017

Joseph D Ma

series ordinal

3

1 reference

3 August 2017

Brookie M Best

series ordinal

4

1 reference

3 August 2017

4 February 2014

1 reference

Journal of Analytical Toxicology

3 August 2017

1 reference

3 August 2017

38

1 reference

3 August 2017

135-142

1 reference

3 August 2017

3

1 reference

Diazepam effects on the cerebral responses to tonic pain: a SPET study

3 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Entry of diazepam and its major matabolite into cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Polydrug abuse: a review of opioid and benzodiazepine combination use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Interaction between grapefruit juice and diazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Development and preliminary application of high-performance liquid chromatographic assay of urinary metabolites of diazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Urinary excretion of diazepam metabolites in healthy volunteers and drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

The characterization of human urine for specimen validity determination in workplace drug testing: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Normalization of urinary drug concentrations with specific gravity and creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

The aging kidney: physiological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Sex-specific differences in CYP450 isoforms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

Diazepam-omeprazole inhibition interaction: an in vitro investigation using human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAT%2FBKU001

21 January 2018

Identifiers

DOI

10.1093/JAT/BKU001

1 reference

3 August 2017

1 reference